Verified from official sourcesLast updated: 2026-04-05

⚠️ Important: Max Robotics is a coordination platform. We are not FCC engineers, lawyers, or a certification body, and we do not guarantee certification approval.

ℹ️ Figures shown are reference-only — always confirm against the latest official sources.

🤝 Need project-specific advice? Match with an independent expert →
Back to blog
FDA📖 6 min read

How to Save $50,000 with $5,000: Product Positioning to Avoid FDA

FDA scope is determined by your INTENDED USE, not your hardware. The right marketing language can keep you out of FDA scope entirely — saving $50K-$200K.

Same hardware, two outcomes: a $200K FDA submission OR a $0 wellness product. The difference is the words you choose. A robot that "monitors heart rate to detect cardiac events" is a Class II medical device requiring 510(k) clearance — $50,000 to $200,000, 9-24 months. The same hardware re-positioned as "tracks wellness data for personal awareness" stays out of FDA scope entirely. Three rules to follow at the design stage: 1. **Avoid medical-claim words in your marketing.** Diagnose, treat, prevent disease, medical-grade, clinical, monitor for medical purposes — every one of these triggers FDA scrutiny. 2. **Use general-wellness alternatives.** Track wellness data. General fitness companion. Personal awareness reminders. Activity log. Social companion. These keep you in the FDA-exempt "general wellness" category. 3. **Disclaim explicitly.** "Not for medical purposes. Not intended to diagnose, treat, cure, or prevent any disease." Put this on the box, in the user manual, and on the e-commerce listing. Real example: an elder-care robot company we worked with originally positioned their product as a "fall detection medical alert system." That positioning would have required FDA 510(k) clearance ($75K base + $40K consultant + $15K clinical data). After re-positioning as a "safety check-in companion," they shipped without FDA — saving $130K and 12 months. The catch: you have to commit at the design stage. After launch, the FDA looks at your marketing materials, your packaging, even your founder's LinkedIn posts. Re-positioning post-launch with FDA already paying attention gets you a warning letter — and then you're stuck. Our recommendation: book a free 30-minute consultation BEFORE finalizing your product brief. We'll tell you frankly whether your concept is FDA-bound or wellness-bound. Most of the time it's avoidable.

Related

Need certification help? Contact us →

Get a free consultation

Tell us about your robot. We respond within 24 hours.

Certifications needed

We respond personally within 24 hours · terry.tao@max-robotics.com

⚠️ Important: Max Robotics is a coordination platform. We are not FCC engineers, lawyers, or a certification body, and we do not guarantee certification approval.

ℹ️ Figures shown are reference-only — always confirm against the latest official sources.

💬 Need help?